Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 460.80
+14.05 (3.14%)
Feb 16, 2026, 3:29 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 9.94 billion as of February 13, 2026. Its market cap has increased by 57.21% in one year.
Market Cap
9.94B
Enterprise Value
10.79B
Revenue
2.31B
Ranking
n/a
PE Ratio
39.30
Stock Price
460.80
Market Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 9.94B, an increase of 1,674.69%. That is a compound annual growth rate of 41.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 9.94B | 9.18% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 33.70B |
| RPG Life Sciences | 32.66B |
| Solara Active Pharma Sciences | 24.07B |
| Indoco Remedies | 18.68B |
| Windlas Biotech | 16.87B |
| Beta Drugs | 13.87B |
| Jagsonpal Pharmaceuticals | 11.68B |
| Ind-Swift Laboratories | 11.10B |